CLINICAL_TRIALS
trial_result
· 2015-10-06
Clinical Trial Update: Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy [Phase 3]
Summary
A Phase 3 trial comparing Teneligliptin (MP-513) to placebo in patients with Type 2 diabetes mellitus on metformin monotherapy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Handok Inc. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED